These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 22096243

  • 1. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
    Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S.
    Blood; 2012 Jan 19; 119(3):673-86. PubMed ID: 22096243
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 19; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan 19; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
    Pathology; 2020 Jan 19; 52(1):111-127. PubMed ID: 31767131
    [Abstract] [Full Text] [Related]

  • 5. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May 19; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 6. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.
    Bone Marrow Transplant; 2003 Jan 19; 31(2):105-11. PubMed ID: 12621491
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.
    Ng SB, Ohshima K, Selvarajan V, Huang G, Choo SN, Miyoshi H, Wang S, Chua HC, Yeoh AE, Quah TC, Koh LP, Tan PL, Chng WJ.
    Orphanet J Rare Dis; 2014 Dec 05; 9():165. PubMed ID: 25475054
    [Abstract] [Full Text] [Related]

  • 8. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr 05; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 9. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L.
    Semin Diagn Pathol; 2020 Jan 05; 37(1):32-46. PubMed ID: 31889602
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H.
    Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684
    [Abstract] [Full Text] [Related]

  • 11. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    Int J Clin Exp Pathol; 2014 Jul 17; 7(5):2430-7. PubMed ID: 24966953
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.
    Am J Hematol; 2008 Sep 17; 83(9):721-7. PubMed ID: 18626884
    [Abstract] [Full Text] [Related]

  • 13. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
    Kawabe S, Ito Y, Gotoh K, Kojima S, Matsumoto K, Kinoshita T, Iwata S, Nishiyama Y, Kimura H.
    Cancer Sci; 2012 Aug 17; 103(8):1481-8. PubMed ID: 22497716
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM, Deng ZJ, Hu B, Hu HL, Chen HY, Li SY, Liu G.
    Zhonghua Er Ke Za Zhi; 2018 Oct 02; 56(10):759-764. PubMed ID: 30293280
    [Abstract] [Full Text] [Related]

  • 15. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K.
    Arch Dermatol; 2006 May 02; 142(5):587-95. PubMed ID: 16702496
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S, NK-cell Tumor Study Group.
    Histopathology; 2011 Oct 02; 59(4):660-71. PubMed ID: 22014047
    [Abstract] [Full Text] [Related]

  • 17. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec 02; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 18. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K.
    Am J Hematol; 2006 Aug 02; 81(8):576-81. PubMed ID: 16823820
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S, Ko YH.
    J Dermatol; 2014 Jan 02; 41(1):29-39. PubMed ID: 24438142
    [Abstract] [Full Text] [Related]

  • 20. Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.
    Gao LM, Zhao S, Zhang WY, Wang M, Li HF, Lizaso A, Liu WP.
    Cancer Biol Ther; 2019 Jan 02; 20(10):1319-1327. PubMed ID: 31311407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.